Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Nieuwdorp

Showing results (371-380 of 416) with videos related to

Pageof 42
Sort By:
Clinical Chemistry and Laboratory Medicine|May 14, 2024
Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)Koen C van Son, Anne-Marieke van Dijk, Stan Driessen, et al.
Plos One|March 2, 2023
Self-organized metabotyping of obese individuals identifies clusters responding differently to bariatric surgeryDimitra Lappa, Abraham S Meijnikman, Kimberly A Krautkramer, et al.
Physiological Reports|August 20, 2019
Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjectsGuido J Bakker, Johan G Schnitzler, Siroon Bekkering, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 15, 2021
Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH CohortMarian A Troelstra, Julia J Witjes, Anne-Marieke van Dijk, et al.
Kidney International|December 4, 2019
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trialErik J M van Bommel, Marcel H A Muskiet, Michaël J B van Baar, et al.
Cell Metabolism|July 14, 2016
Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled TrialDorien Reijnders, Gijs H Goossens, Gerben D A Hermes, et al.
Cell Metabolism|August 11, 2016
Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled TrialDorien Reijnders, Gijs H Goossens, Gerben D A Hermes, et al.
Journal of the American Heart Association|March 28, 2018
Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic SyndromeLoek P Smits, Ruud S Kootte, Evgeni Levin, et al.
Gut|June 1, 2019
Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit timePieter de Groot, Torsten Scheithauer, Guido J Bakker, et al.
Diabetes|June 17, 2022
Hyperinsulinemia Is Highly Associated With Markers of Hepatocytic Senescence in Two Independent CohortsAbraham S Meijnikman, Casper C van Olden, Ömrüm Aydin, et al.
Pageof 42

Showing results (371-380 of 416) with videos related to

Sort By:
Pageof 42
Clinical Chemistry and Laboratory Medicine|May 14, 2024
Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)Koen C van Son, Anne-Marieke van Dijk, Stan Driessen, et al.
Plos One|March 2, 2023
Self-organized metabotyping of obese individuals identifies clusters responding differently to bariatric surgeryDimitra Lappa, Abraham S Meijnikman, Kimberly A Krautkramer, et al.
Physiological Reports|August 20, 2019
Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjectsGuido J Bakker, Johan G Schnitzler, Siroon Bekkering, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 15, 2021
Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH CohortMarian A Troelstra, Julia J Witjes, Anne-Marieke van Dijk, et al.
Kidney International|December 4, 2019
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trialErik J M van Bommel, Marcel H A Muskiet, Michaël J B van Baar, et al.
Cell Metabolism|July 14, 2016
Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled TrialDorien Reijnders, Gijs H Goossens, Gerben D A Hermes, et al.
Cell Metabolism|August 11, 2016
Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled TrialDorien Reijnders, Gijs H Goossens, Gerben D A Hermes, et al.
Journal of the American Heart Association|March 28, 2018
Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic SyndromeLoek P Smits, Ruud S Kootte, Evgeni Levin, et al.
Gut|June 1, 2019
Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit timePieter de Groot, Torsten Scheithauer, Guido J Bakker, et al.
Diabetes|June 17, 2022
Hyperinsulinemia Is Highly Associated With Markers of Hepatocytic Senescence in Two Independent CohortsAbraham S Meijnikman, Casper C van Olden, Ömrüm Aydin, et al.
Pageof 42